Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment. - Wikidata - wikimedia - TriplyDB

Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.

Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.

http://www.wikidata.org/entity/Q36975446

about

Effects of performance measure implementation on clinical manager and provider motivation Using benefit-based tailored treatment to improve the use of antihypertensive medications.Clinically relevant quality measures for risk factor control in primary care: a retrospective cohort study.Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008.Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study Developing and Testing an Electronic Measure of Screening Colonoscopy Overuse in a Large Integrated Healthcare System.Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study.Quality indicators and performance measures in diabetes care.A Systematic Review of Patient Safety Measures in Adult Primary Care.Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.Pay-for-Performance and Veteran Care in the VHA and the Community: a Systematic Review

P2860

Q27312901-6854F031-32F4-434F-9312-4A7BA62228F0 Q33632026-8DB799FA-41D1-4A96-82A9-F3AAE6BE3313 Q33929231-66FF6455-B625-48C8-A596-1995CD1D781D Q34516311-A47B5199-9F06-494B-8CED-B081E9C0466B Q36110666-61F9995A-0D9B-489C-ADEC-540E31C7B3A3 Q36717508-35FA1EEC-DCB6-4CC0-8148-DA1EBECEC920 Q36823179-1B8BD7BB-FBB6-472D-8BD6-53CE126C4FE1 Q36962326-5E5AD14A-18D5-4EE9-99CE-3F6F238EFA69 Q37604972-08A75999-D7B8-42F2-BF8C-790C236A54F4 Q38185302-63C79B04-1CE7-4691-802F-3FFD0B4EBE98 Q38818428-F28F08BC-F2D8-4753-AAE2-0235E350B4DD Q40070444-DB638D9D-8058-4D1A-AB5F-99FE73460590 Q56395728-4E688582-455D-41CD-973E-306651568E6B

P2860

Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment.

http://www.wikidata.org/entity/Q36975446

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Assessing appropriateness of l ...... ving from target to treatment.

@en

type

label

Assessing appropriateness of l ...... ving from target to treatment.

@en

prefLabel

Assessing appropriateness of l ...... ving from target to treatment.

@en

P1433

Q36975446-205AA2CF-D550-466D-AE18-B5DD12E52504

P1476

Q36975446-5FA2B857-BC5E-4948-A91E-A737C2089609

P2093

Q36975446-39EC91E8-0106-4155-8012-2970551F8771

Q36975446-4AC561E0-55D3-4EF1-BA3F-F17A50D4C2A6

Q36975446-67F3D760-9115-42A4-AB06-53DC36BA8962

Q36975446-693ECA26-086E-4C31-B812-35EFE8C72DCF

Q36975446-782FCCD2-4DF4-42C3-852E-7B03428F1325

Q36975446-8F234336-DD63-43DF-9829-9974F4FA61EF

Q36975446-9652CC1D-4E79-49BC-8BF7-E815186E0F50

Q36975446-F0F1C20F-C397-4599-A41A-0742508E7D76

P2860

Q36975446-000D0622-5E2F-42D3-BFB8-D332239C2EA0

Q36975446-0AA0AE93-92D3-4F3E-B260-C367CF557A27

Q36975446-0E2C2B64-7E42-4B75-BD7B-B78C36B082F3

Q36975446-1517B4A0-D317-401C-A4A9-3707D5ECAA10

Q36975446-1F2EC51B-39BC-47D2-BE45-E0633FE37801

Q36975446-2B89D1E2-6EC3-488C-A829-9925AF652A3C

Q36975446-2D9F67F9-E811-40BB-8E43-D6B74CB512F9

Q36975446-380ABA81-58AF-499D-A2AF-59C3C89C3501

Q36975446-41F6DD0D-6432-41D9-BBF2-607894CD3FF0

Q36975446-46AD42DE-F7CD-4225-8BC1-F3AEA9C2CB9E

P304

Q36975446-AFF32E74-F011-495C-B808-B73D576F6449

P31

Q36975446-221793A8-B27B-4F2A-A994-E86093D9D052

P356

Q36975446-BD57B49D-91D3-44B9-9234-9CEE5154BEF4

P433

Q36975446-15A3E286-2765-473F-A790-6010311889B6

P478

Q36975446-B4051D75-9571-487C-B2C0-7900104A13DD

P577

Q36975446-0E6C5F88-456F-41DD-93BB-40AE2322D93B

P698

Q36975446-40EFE2AA-F953-4F08-B5C0-2A2F6C9DE0DC

P932

Q36975446-88E48FF4-4AEA-43B5-9C49-0C95C75E4E92

P356

CIRCOUTCOMES.112.966697

P1433

Circulation: Cardiovascular Quality and Outcomes

P1476

Assessing appropriateness of l ...... ving from target to treatment.

@en

P2093

Ashley J Beard

http://www.w3.org/2001/XMLSchema#string

Diabetes Clinical Action Measures Workgroup

http://www.w3.org/2001/XMLSchema#string

Eve A Kerr

http://www.w3.org/2001/XMLSchema#string

John R Downs

http://www.w3.org/2001/XMLSchema#string

Mandi L Klamerus

http://www.w3.org/2001/XMLSchema#string

Michelle Lucatorto

http://www.w3.org/2001/XMLSchema#string

Rob Holleman

http://www.w3.org/2001/XMLSchema#string

Timothy P Hofer

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

P304

66-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCOUTCOMES.112.966697

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23233749

http://www.w3.org/2001/XMLSchema#string

P932

3699178

http://www.w3.org/2001/XMLSchema#string